Author:
Lv Zhijie,Zhang Xiaoqi,Wu Li
Abstract
Abstract
Background
Infliximab-induced seizures in patients with Crohn’s disease are extremely rare and the mechanism of infliximab-induced seizures is unclear.
Case presentation
A 60-year-old woman with Crohn’s disease experienced infliximab-induced seizures, diagnosed on normal magnetic resonance imaging of the brain. Moreover, the rechallenge with infliximab was positive.
Conclusions
Neurological assessment and tight clinical monitoring before and during therapy with infliximab should be performed in patients with pre-existing seizure disorders.
Funder
Health Commission of Zhejiang Province
Zhejiang Chinese Medical University
Publisher
Springer Science and Business Media LLC
Subject
Gastroenterology,General Medicine
Reference15 articles.
1. Khanna D, McMahon M, Furst DE. Safety of tumour necrosis factor-alpha antagonists. Drug Saf. 2004;27(5):307–24.
2. Melsheimer R, Geldhof A, Apaolaza I, Schaible T. Remicade® (infliximab): 20 years of contributions to science and medicine. Biologics. 2019;13:139 – 78.
3. Aubin F, Carbonnel F, Wendling D. The complexity of adverse side-effects to biological agents. J Crohns Colitis. 2013;7(4):257–62.
4. Bramuzzo M, Arrigo S, Romano C, et al. Efficacy and safety of infliximab in very early onset inflammatory bowel disease: a national comparative retrospective study. Unit Eur Gastroenterol J. 2019;7(6):759–66.
5. Zaltman C, Amarante H, Brenner MM, et al. Crohn’s disease-treatment with biological medication. Rev Assoc Med Bras. 2019;65(4):554–67.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Side Effects of Gastrointestinal Drugs;Side Effects of Drugs Annual;2022
2. Infliximab;Reactions Weekly;2021-06